Institutional investors purchased a net $7.7 million shares of LCTX during the quarter ended June 2019 and now own 43.79% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LAURION CAPITAL MANAGEMENT LP Bought 2.4 Million shares of Lineage Cell Therapeutics...